Parents Can Receive Alerts If Their Child Experiences Acute Distress While Using ChatGPT | OpenAI

When a teenager exhibits significant distress while interacting with ChatGPT, parents might receive a notification if their child displays signs of distress, particularly in light of child safety concerns, as more young individuals seek support and advice from AI chatbots.

This alert is part of new protective measures for children that OpenAI plans to roll out next month, following a lawsuit from a family whose son reportedly received “months of encouragement” from the chatbot.

Among the new safeguards is a feature that allows parents to link their accounts with their teenagers’, enabling them to manage how AI models respond to their children through “age-appropriate model behavior rules.” However, internet safety advocates argue that progress on these initiatives has been slow and assert that AI chatbots should not be released until they are deemed safe for young users.

Adam Lane, a 16-year-old from California, tragically took his life in April after discussing methods of suicide with ChatGPT, which allegedly offered to assist him in crafting a suicide note. OpenAI has acknowledged deficiencies in its system and admits that safety training for AI models has declined throughout extended conversations.

Raine’s family contends that the chatbot was “released to the market despite evident safety concerns.”

“Many young people are already interacting with AI,” OpenAI stated. The blog outlines their latest initiatives. “They are among the first ‘AI natives’ who have grown up with these tools embedded in their daily lives, similar to earlier generations with the internet and smartphones. This presents genuine opportunities for support, learning, and creativity; however, it also necessitates that families and teens receive guidance to establish healthy boundaries corresponding to the unique developmental stages of adolescence.”

A significant change will allow parents to disable AI memory and chat history, preventing past comments about personal struggles from resurfacing in ways that could exacerbate risk and negatively impact a child’s long-term profile and mental well-being.

In the UK, the Intelligence Committee has established a Code of Practice regarding the design of online services that are suitable for children, advising tech companies to “collect and retain only the minimum personal data necessary for providing services that children are actively and knowingly involved in.”

Around one-third of American teens utilize AI companions for social interactions and relationships, including role-playing, romance, and emotional support, according to a study. In the UK, 71% of vulnerable children engage with AI chatbots, with six in ten parents reporting their children believe these chatbots are real people, as highlighted in another study.

The Molly Rose Foundation, established by the father of Molly Russell, who took her life after succumbing to despair on social media, emphasized that “we shouldn’t introduce products to the market before confirming they are safe for young people; efforts to enhance safety should occur beforehand.”

Andy Burrows, the foundation’s CEO, stated, “We look forward to future developments.”

“OFCOM must be prepared to investigate violations committed by ChatGPT, prompting the company to adhere to online safety laws that must ensure user safety,” he continued.


Anthropic, the company behind the popular Claude chatbot, states that its platform is not intended for individuals under 18. In May, Google permitted children under 13 to access its app using the Gemini AI system. Google also advises parents to inform their children that Gemini is not human and cannot think or feel and warns that “your child may come across content you might prefer them to avoid.”

The NSPCC, a child protection charity, has welcomed OpenAI’s initiatives as “a positive step forward, but it’s insufficient.”

“Without robust age verification, they cannot ascertain who is using their platform,” stated senior policy officer Toni Brunton Douglas. “This leaves vulnerable children at risk. Technology companies should prioritize child safety rather than treating it as an afterthought. It’s time to establish protective defaults.”

Meta has implemented protection measures for teenagers in its AI offerings, stating that for sensitive topics like self-harm, suicide, and disability, it will “incorporate additional safeguards, training AI to redirect teens to expert resources instead.”

“These updates are in progress, and we will continue to adjust our approach to ensure teenagers have a secure and age-appropriate experience with AI,” a spokesperson mentioned.

Source: www.theguardian.com

Revolutionary New Test Promises Breakthrough in Acute Myeloid Leukemia Treatment

A breakthrough assay to detect acute myeloid leukemia (AML) through a KMT2A gene fusion promises to enhance diagnosis and treatment and represents a major advance in leukemia research.


The researchers Accuracy
Detecting specific molecular markers within leukemia cells has the potential to significantly improve the assessment of measurable residual disease. This advancement will enable better-informed treatment decisions and ultimately improve patient outcomes.

A new assay that detects unique molecular markers in patients with acute myeloid leukemia (AML) could revolutionize how the disease is detected and treated, according to a recently published new report. Molecular Diagnostic Journal Published by Elsevier. This assay may improve the detection of AML due to factors such as: Kuomintang 2A Gene fusions can impact treatment decision-making, assessment of response to treatment, and long-term monitoring.

AML is a rare, aggressive blood cancer that is diagnosed in approximately 120,000 people worldwide each year. Detecting residual disease during treatment is essential to determine prognosis and guide treatment decisions.Currently, methods to detect measurable residual disease (MRD) during treatment of AML include bone marrow morphology, multiparameter flow cytometry (MPFC), and DNA Sequencing.

Morphological evaluation detects leukemic cells only with a detection limit of 5%. Although MPFC has a more sensitive detection limit of 0.01% to 0.001%, it is difficult to implement and interpret and is not standardized across laboratories. DNA sequencing approaches can identify leukemic cells by somatic mutation profiles, but are expensive and can be confounded by clonal hematopoiesis in nonleukemic blood cells.

Breakthrough progress in leukemia research

“We’ve seen a lot of research in this field,” explained lead researcher Dr. Grant A. Challen, of the Department of Oncology at Washington University School of Medicine in St. Louis. Normally absent in healthy cells. Other diseases such as chronic myeloid leukemia (CML) can already be tracked by standard BCR-ABL fusions, and sensitive detection of these fusions has revolutionized the way CML is treated. . For AML patients whose disease is caused by oncogenic fusions, the KMT2A fusion is a molecular marker that can be exploited for sensitive MRD detection. Therefore, we wanted to develop a platform for sensitive KMT2A fusion detection to improve detection and treatment methods for this disease. ”

Researchers have developed a new droplet digital PCR assay that allows for high sensitivity. Kuomintang 2A Fusion detection with the five most common fusion partners.At least 80 are known Kuomintang 2A There are fusion partners, but approximately 80% of fusions involve only 5 partners – AF9, AF6, AF4, Elleand English. They benchmarked the assay in human cell lines and patient samples and demonstrated sensitivity and specificity. Kuomintang 2A Fusion detection.

This assay detects these fusions by splitting cDNA molecules into microfluidic droplets and assaying them using primers and probes that generate a positive signal only when the fused transcript is present. Researchers were able to combine multiple primer/probe sets targeting different fusions into a pooled fusion detection reagent. they again, Kuomintang 2A Fusions in patient samples are known to be present Kuomintang 2A fusion.

Implications for AML treatment and future research

Dr. Challen said: This assay can be easily extended to include additional oncogenic fusions. This has potential implications for treatment decision-making and assessment of response to treatment. Knowing whether treatment is effective is critical to deciding when to escalate treatment or perform a hematopoietic stem cell transplant. ”

“This is a powerful new tool for highly sensitive KMT2A fusion detection and can be directly applied to disease detection in leukemia patients caused by these fusions. This fills a void in oncogenic fusion detection. , we offer several technical improvements. This assay is also highly scalable, and additional fusions can be easily added to the assay to expand coverage of other oncogenic fusions. We is improving blood cancer detection one drop at a time.”

Reference: “Droplet Digital PCR for Oncogenic KMT2A Fusion Detection” by Andrew L. Young, Hannah C. Davis, and Grant A. Challen, October 7, 2023. Molecular Diagnostic Journal.
DOI: 10.1016/j.jmoldx.2023.09.006

This research was funded by: National Institutes of Health and the Leukemia and Lymphoma Society.

Source: scitechdaily.com